JP2023529196A5 - - Google Patents
Info
- Publication number
- JP2023529196A5 JP2023529196A5 JP2022575898A JP2022575898A JP2023529196A5 JP 2023529196 A5 JP2023529196 A5 JP 2023529196A5 JP 2022575898 A JP2022575898 A JP 2022575898A JP 2022575898 A JP2022575898 A JP 2022575898A JP 2023529196 A5 JP2023529196 A5 JP 2023529196A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administration
- composition according
- compound
- cmax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038664P | 2020-06-12 | 2020-06-12 | |
| US63/038,664 | 2020-06-12 | ||
| PCT/US2021/037098 WO2021252959A1 (en) | 2020-06-12 | 2021-06-11 | Sulcardine administration for treatment of acute atrial fibrillation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529196A JP2023529196A (ja) | 2023-07-07 |
| JP2023529196A5 true JP2023529196A5 (cg-RX-API-DMAC10.html) | 2024-06-18 |
Family
ID=78824214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575898A Pending JP2023529196A (ja) | 2020-06-12 | 2021-06-11 | 急性心房細動の治療のためのサルカルディン投与 |
Country Status (14)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11813245B2 (en) * | 2020-06-12 | 2023-11-14 | Huyabio International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| WO2026036095A1 (en) * | 2024-08-08 | 2026-02-12 | Huyabio International, Llc | J-Tp PROTECTION |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) * | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1939298A (zh) | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| US8541464B2 (en) * | 2009-11-17 | 2013-09-24 | HUYA Biosciences International LLC | Treatment of atrial fibrillation |
| WO2011062903A2 (en) * | 2009-11-17 | 2011-05-26 | Elliott Gary T | Slow infusion of sulcardine and its salts |
| EP3302442B1 (en) | 2015-06-03 | 2024-10-16 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| AU2018212273B2 (en) | 2017-01-26 | 2023-12-21 | Triastek, Inc. | Dosage forms of controlled release at specific gastrointestinal sites |
| WO2020123824A1 (en) * | 2018-12-13 | 2020-06-18 | Huya Bioscience International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| KR102405199B1 (ko) * | 2019-01-29 | 2022-06-02 | 후야 바이오사이언스 인터내셔널 엘엘씨 | 설카딘 염 |
| US11813245B2 (en) * | 2020-06-12 | 2023-11-14 | Huyabio International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
-
2021
- 2021-06-11 US US17/345,564 patent/US11813245B2/en active Active
- 2021-06-11 CN CN202180055470.6A patent/CN116723836A/zh active Pending
- 2021-06-11 JP JP2022575898A patent/JP2023529196A/ja active Pending
- 2021-06-11 PH PH1/2022/553396A patent/PH12022553396A1/en unknown
- 2021-06-11 MX MX2022015834A patent/MX2022015834A/es unknown
- 2021-06-11 WO PCT/US2021/037098 patent/WO2021252959A1/en not_active Ceased
- 2021-06-11 EP EP21823026.6A patent/EP4164633A4/en active Pending
- 2021-06-11 BR BR112022025216A patent/BR112022025216A2/pt unknown
- 2021-06-11 KR KR1020237000723A patent/KR20230024347A/ko active Pending
- 2021-06-11 CA CA3182015A patent/CA3182015A1/en active Pending
- 2021-06-11 IL IL298907A patent/IL298907A/en unknown
- 2021-06-11 AU AU2021288056A patent/AU2021288056A1/en active Pending
-
2022
- 2022-12-09 CL CL2022003501A patent/CL2022003501A1/es unknown
-
2023
- 2023-01-10 CO CONC2023/0000194A patent/CO2023000194A2/es unknown
- 2023-10-11 US US18/484,823 patent/US12465587B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102056603A (zh) | 决奈达隆用于预防持续性心房纤颤 | |
| JP2024540183A5 (cg-RX-API-DMAC10.html) | ||
| JP2021504423A5 (cg-RX-API-DMAC10.html) | ||
| JP2016153413A (ja) | 肺高血圧症のための治療 | |
| JPS60188323A (ja) | 心筋虚血治療用医薬組成物 | |
| US12396970B2 (en) | Anti-arrhythmic compositions and methods | |
| KR102268161B1 (ko) | 빈맥성부정맥 및 고혈압의 장기 치료에서 란디오롤 하이드로클로라이드의 용도 | |
| JP2022514537A5 (cg-RX-API-DMAC10.html) | ||
| JP2012502047A (ja) | 心房細動を治療する方法 | |
| GB2581431A (en) | Compositions, devices, and methods for treating or preventing headaches | |
| RU2731918C2 (ru) | Хорошо растворимые в воде соли фенилалкиламина - быстродействующего блокатора кальциевых каналов и их применение | |
| CN113876775A (zh) | 一种青藤碱或其药物可接受的盐作为治疗动脉性肺动脉高压药物的用途 | |
| KR20230024347A (ko) | 급성 심방 세동의 치료를 위한 설카르딘 투여 | |
| CN1127336C (zh) | 肺性心病治疗剂 | |
| RU2245147C2 (ru) | Применение ингибитора вазопептидазы для лечения стенокардии | |
| JP7137852B2 (ja) | ９‐β‐Ｄ‐アラビノフラノシルヒポキサンチンによる不整脈治療 | |
| JPH0552813B2 (cg-RX-API-DMAC10.html) | ||
| JP2010248263A (ja) | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 | |
| JP4784037B2 (ja) | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 | |
| JPH10139664A (ja) | 抗不整脈薬 | |
| WO2007023775A1 (ja) | 心房細動治療剤 | |
| EP2387996A1 (en) | Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation | |
| HK1214511B (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| GOULD et al. | SHARIFF,** MD, and Marguerite GIULIANI,** MD | |
| JPS645573B2 (cg-RX-API-DMAC10.html) |